Rosemount Pharmaceuticals

Rosemont Pharmaceuticals is a specialty pharmaceutical company based in the United Kingdom that focuses on the development, manufacture, and marketing of oral liquid medicines. The company is a pioneer in providing liquid alternatives for patients who have difficulty swallowing solid dosage forms, a condition known as dysphagia, which is common among elderly and pediatric populations. Their portfolio includes over 130 oral liquid products across a wide range of therapeutic areas, including cardiology, endocrinology, and neurology. Acquired by Perrigo in 2013, Rosemont continues to be a leading supplier of liquid medications to the healthcare sector, including the National Health Service (NHS).